Your browser doesn't support javascript.
loading
Implementation of DNA Methylation Array Profiling in Pediatric Central Nervous System Tumors: The AIM BRAIN Project: An Australian and New Zealand Children's Haematology/Oncology Group Study.
White, Christine L; Kinross, Kathryn M; Moore, Molly K; Rasouli, Elnaz; Strong, Robyn; Jones, Janelle M; Cain, Jason E; Sturm, Dominik; Sahm, Felix; Jones, David T W; Pfister, Stefan M; Robertson, Thomas; D'Arcy, Colleen; Rodriguez, Michael L; Dyke, Jason M; Junckerstorff, Reimar; Bhuva, Dharmesh D; Davis, Melissa J; Wood, Paul; Hassall, Tim; Ziegler, David S; Kellie, Stewart; McCowage, Geoffrey; Alvaro, Frank; Kirby, Maria; Heath, John A; Tsui, Karen; Dodgshun, Andrew; Eisenstat, David D; Khuong-Quang, Dong-Anh; Wall, Meaghan; Algar, Elizabeth M; Gottardo, Nicholas G; Hansford, Jordan R.
Afiliação
  • White CL; Hudson Institute of Medical Research, Clayton, Victoria, Australia; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia; Victorian Clinical Genetics Services, Parkville, Victoria, Australia.
  • Kinross KM; Hudson Institute of Medical Research, Clayton, Victoria, Australia; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia; Australian and New Zealand Children's Haematology/Oncology Group, Clayton, Victoria, Australia.
  • Moore MK; Hudson Institute of Medical Research, Clayton, Victoria, Australia; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia.
  • Rasouli E; Hudson Institute of Medical Research, Clayton, Victoria, Australia; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia.
  • Strong R; Hudson Institute of Medical Research, Clayton, Victoria, Australia; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia; Australian and New Zealand Children's Haematology/Oncology Group, Clayton, Victoria, Australia.
  • Jones JM; Hudson Institute of Medical Research, Clayton, Victoria, Australia; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia; Australian and New Zealand Children's Haematology/Oncology Group, Clayton, Victoria, Australia.
  • Cain JE; Hudson Institute of Medical Research, Clayton, Victoria, Australia; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia.
  • Sturm D; Hopp Children's Cancer Centre Heidelberg, Heidelberg, Germany; Division of Pediatric Glioma Research, German Cancer Research Center and German Cancer Consortium, Heidelberg, Germany; Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, Heidelberg, Germany.
  • Sahm F; Hopp Children's Cancer Centre Heidelberg, Heidelberg, Germany; Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany; Clinical Cooperation Unit Neuropathology, German Cancer Research Center and German Cancer Consortium, Heidelberg, Germany.
  • Jones DTW; Hopp Children's Cancer Centre Heidelberg, Heidelberg, Germany; Division of Pediatric Glioma Research, German Cancer Research Center and German Cancer Consortium, Heidelberg, Germany.
  • Pfister SM; Hopp Children's Cancer Centre Heidelberg, Heidelberg, Germany; Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, Heidelberg, Germany; Division of Pediatric Neurooncology, German Cancer Research Center and German Cancer Consortium, Heidelberg, Germany.
  • Robertson T; Royal Brisbane and Women's Hospital, Herston, Queensland, Australia.
  • D'Arcy C; Department of Pathology, Royal Children's Hospital, Parkville, Victoria, Australia.
  • Rodriguez ML; Sydney Children's Hospital, Randwick, New South Wales, Australia.
  • Dyke JM; PathWest Neuropathology, Royal Perth Hospital, Perth, Western Australia, Australia; Pathology and Laboratory Medicine, University of Western Australia, Nedlands, Western Australia, Australia.
  • Junckerstorff R; PathWest Neuropathology, Royal Perth Hospital, Perth, Western Australia, Australia; Pathology and Laboratory Medicine, University of Western Australia, Nedlands, Western Australia, Australia.
  • Bhuva DD; Walter and Eliza Hall Institute, Melbourne, Victoria, Australia; South Australia ImmunoGENomics Cancer Institute, University of Adelaide, Adelaide, South Australia, Australia.
  • Davis MJ; Walter and Eliza Hall Institute, Melbourne, Victoria, Australia; South Australia ImmunoGENomics Cancer Institute, University of Adelaide, Adelaide, South Australia, Australia.
  • Wood P; Monash Children's Hospital, Clayton, Victoria, Australia.
  • Hassall T; Queensland Children's Hospital, South Brisbane, Queensland, Australia.
  • Ziegler DS; Kids Cancer Centre, Sydney Children's Hospital, Randwick, New South Wales, Australia; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales (UNSW), Kensington, New South Wales, Australia; School of Clinical Medicine, UNSW Medicine and Health, UNSW Sydney, Sydney, Ne
  • Kellie S; The Children's Hospital at Westmead, Westmead, New South Wales, Australia.
  • McCowage G; The Children's Hospital at Westmead, Westmead, New South Wales, Australia.
  • Alvaro F; John Hunter Children's Hospital, New Lambton Heights, New South Wales, Australia.
  • Kirby M; Women's and Children's Hospital, North Adelaide, South Australia, Australia.
  • Heath JA; Royal Hobart Hospital, Hobart, Tasmania, Australia.
  • Tsui K; Starship Children's Hospital, Grafton, Auckland, New Zealand.
  • Dodgshun A; Christchurch Hospital, Christchurch Central City, Christchurch, New Zealand.
  • Eisenstat DD; Children's Cancer Centre, Royal Children's Hospital, Parkville, Victoria, Australia; Murdoch Children's Research Institute, Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia.
  • Khuong-Quang DA; Children's Cancer Centre, Royal Children's Hospital, Parkville, Victoria, Australia.
  • Wall M; Victorian Clinical Genetics Services, Parkville, Victoria, Australia.
  • Algar EM; Hudson Institute of Medical Research, Clayton, Victoria, Australia; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia. Electronic address: elizabeth.algar@monash.edu.
  • Gottardo NG; Perth Children's Hospital, Nedlands, Western Australia, Australia; Telethon Kids Institute, Nedlands, Western Australia, Australia.
  • Hansford JR; South Australia ImmunoGENomics Cancer Institute, University of Adelaide, Adelaide, South Australia, Australia; Women's and Children's Hospital, North Adelaide, South Australia, Australia; Children's Cancer Centre, Royal Children's Hospital, Parkville, Victoria, Australia; Murdoch Children's Research
J Mol Diagn ; 25(10): 709-728, 2023 10.
Article em En | MEDLINE | ID: mdl-37517472
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Sistema Nervoso Central / Metilação de DNA Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies Limite: Child / Humans País/Região como assunto: Oceania Idioma: En Revista: J Mol Diagn Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Sistema Nervoso Central / Metilação de DNA Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies Limite: Child / Humans País/Região como assunto: Oceania Idioma: En Revista: J Mol Diagn Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália